Session 22

OESO-SEMPIRE 16th World Conference | Esophagus 2024 | Strasbourg | April 23-26, 2024 | Venue: IRCAD France

<  back to Program at a glance
<  back to all the scientific sessions

1. Do we know the natural history of EoE? – Adriana Lazarescu (Canada)
2. What is the best initial therapy for the symptomatic EoE patient?
   I. Proton pump inhibitors – Walter W. Chan (USA) 
   II. Dietary elimination – Mark R. Fox (Switzerland) 
   III. Swallowed topical steroids – Brent Hiramoto (USA) 
   IV. Dupilumab – John O. Clarke (USA) 
3. Are there any non-invasive means to assess inflammation? – Edoardo V. Savarino (Italy)
4. Should all EoE providers be performing FLIP for EoE endoscopies? – Abraham Khan (USA)
5. Does chronic EoE-related esophageal inflammation increase the risk of cancer? – David Wang (USA) 
6. How will we treat EoE in 10 years? – Emily McGowan (USA)